On the contrary, individuals with the GSTO1*CA genotype had significantly lower odds of symptomatic diabetes development compared to the carriers of the wild-type GSTO1*CC genotype (OR = 0.28, 95%CI = 0.15–0.51, p < 0.001). This evidence concerns the gene GSTO1 and diabetes mellitus.